Palonosetron
NDC 67184-0515, Palonosetron Hydrochloride, injection, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0515
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205648
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0515 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALONOSETRON HYDROCHLORIDE.075 mg/1.5mL
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0515-2 | 67184051502 | 5 VIAL in 1 CARTON (67184-0515-2) / 1.5 mL in 1 VIAL (67184-0515-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/633abdc2-a942-4eb2-a0f8-f9f4e727211e
Use it
Look up 67184-0515 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0515 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0515. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.